ASP Isotopes extended its losing streak to a third day on Tuesday, shedding 5.08 percent to close at $5.42 apiece as ...
The listed firm is a Detroit-based fintech platform that owns mortgage, real estate, and personal finance businesses, namely ...
Eli Lilly and Company (NYSE:LLY) is moving quickly to lock in its position in India’s fast-growing obesity drug market.
On December 10, Deutsche Bank analyst George Hill raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $904 ...
On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...
On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc.
On December 15, BofA lowered the firm’s price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating.
Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year, supported by strong financial results and steady ...
On December 9, Barclays analyst Glen Santangelo initiated coverage of Viatris Inc. (NASDAQ:VTRS) with an Overweight rating ...
On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback